The current PE ratio for Medifast stock as of May 3, 2024 is 4.3. This is calculated based on the TTM EPS of $6.21 and the stock price of $26.69 per share. The PE ratio has decreased by 38% from its last 4 quarters average of 7.0.
The average historical PE ratio of Medifast for the last ten years is 21.03. The current price-to-earnings ratio of 4.3 is 80% less than the historical average. Analyzing the last ten years, MED's PE ratio reached its highest point in the Sep 2018 quarter at 56.09, when the price was $221.55 and the EPS was $3.95. The lowest point was recorded in the Mar 2024 quarter, when it reached 6.17 with a price of $38.32 and an EPS of $6.21.
Maximum annual increase: 114.78% in 2014
Maximum annual decrease: -43.96% in 2015
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 7.36 | -18.22% |
| 2022 | 9 | -39.8% |
| 2021 | 14.95 | -33.44% |
| 2020 | 22.46 | 35.71% |
| 2019 | 16.55 | -38.18% |
| 2018 | 26.77 | -11.03% |
| 2017 | 30.09 | 9.14% |
| 2016 | 27.57 | 52.49% |
| 2015 | 18.08 | -43.96% |
| 2014 | 32.26 | 114.78% |
Currently, MED's PE ratio is under its 3, 5 and 10-year averages.
MED's PE ratio is below its peer stock WTW.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MED Medifast Inc | 4.3 | $291.92M |
| WTW Willis Towers Watson Plc | 25.33 | $25.76B |
| ABEO Abeona Therapeutics Inc | N/A | $125.83M |
As of May 3, 2024, MED stock has a price to earnings ratio of 4.3.
Over the last 3 years, the average PE ratio for MED stock is 10.82.
Over the last 5 years, the average PE ratio for MED stock is 13.9.
Over the last ten years, the quarterly PE ratio reached its highest level at 56.09 in the Sep 2018 quarter.
The current PE ratio of MED is 80% lower than the 10-year historical average.
MED's stock price is trading at a lower multiple of earnings, which is why its PE ratio of 4.3 is considered low.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (May 3, 2024), Medifast's share price is $26.69. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $6.21. Therefore, Medifast's price to earnings ratio for today is 4.3. PE RATIO(4.3) = STOCK PRICE($26.69) / TTM EPS($6.21)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.